Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

But they don’t provide patient services or produce a tangible product — they simply ... employers and labor unions. The problem is as PBM profits soar, this success has not resulted in drug savings ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Employers were asked to rate their satisfaction with their PBMs on 16 PBM services. Findings are based on responses from 472 large employers (more than 2500 employees) representing 11.7 million ...

Rescription is the Anti-PBM solution that leverages the capabilities of its health ... and commitment to excellence. With a broad suite of services and specialties, differentiated capital structure, ...

Pennsylvania State Grange. Matthew Espenshade is president of the Pennsylvania State Grange.

particularly in specialty pharmacy and pharmacy benefit management (PBM) services, has positioned it as a leader in the market. However, potential regulatory changes and merger discussions with ...

particularly in specialty pharmacy and pharmacy benefit management (PBM) services, has positioned it as a leader in the market. However, potential regulatory changes and merger discussions with Humana ...

Strengths: Robust Pharmacy Benefit Management and Health Insurance Services. Weaknesses: Vulnerability to Market Fluctuations and Regulatory Changes. Opportunities: Expansion into Emerging Markets ...

The Rhode Island suit and the Community Care suits both use the same PBM ownership and PBM services' market share charts from a recently released Federal Trade Commission interim staff report on PBMs.

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

Strengths: Robust Pharmacy Benefit Management and Health Insurance Services. Weaknesses: Vulnerability to Market Fluctuations and Regulatory Changes. Opportunities: Expansion into Emerging Markets and ...